Project

PANELFIT H2020 EU Project

Goal: Participatory Approaches to a New Ethical and Legal Framework for ICT (PANELFIT) Changes in the EU´S regulation of ICT research and innovation are opening a new scenario. Stakeholders, policy makers, and end users must adapt to them as soon as possible. This, however, might be hard. PANELFIT, a European Commission research´s project, is firmly committed to facilitating this adaptation process. Funding: >2790000 EUR. https://cordis.europa.eu/project/rcn/218355/en

Updates
0 new
13
Recommendations
0 new
6
Followers
0 new
16
Reads
0 new
552

Project log

Inigo DE MIGUEL BERIAIN
added a research item
: Voluntary disclosure of data is becoming an increasingly common practice. The problem is that these actions can seriously harm the relatives of those make such disclosures. This could happen with genetic data, which belongs to all persons about whom it provides information, regardless of who the sample donor is. What can be done in this situation? We defend the idea that they are the rights conferred by the GDPR to data subjects. On this basis, any processing of genetic data should be seen as an exercise of balancing interests, except where the need to respect professional secrecy requires otherwise.
Guillermo Lazcoz
added a research item
Trabajo publicado en Ius et Scientia (Vol. 6, núm. 2, 2020). El pasado 20 de octubre de 2020, el Parlamento Europeo aprobó una Resolución (2020/2012(INL)) con recomendaciones destinadas a la Comisión sobre inteligencia artificial, robótica y tecnologías conexas, entre las cuales, se recoge una propuesta legislativa para la tramitación de un Reglamento sobre los principios éticos para el desarrollo, el despliegue y el uso de dichas tecnologías. El contenido de esta propuesta deriva, sin lugar a duda, de la visión regulatoria que la Comisión Europea ha mantenido en documentos como el Libro Blanco sobre Inteligencia Artificial (COM(2020) 65 final) o las Directrices éticas para una IA fiable elaboradas por el Grupo independiente de expertos de alto nivel. Ante este nuevo horizonte normativo, se hace más necesario que nunca abordar una crítica constructiva de la propuesta, destacando la necesidad o no de reformular su marcado carácter de soft law a pesar de ubicarse en una fuente normativa de alcance general y eficacia directa como los Reglamentos, o el desarrollo de algunos principios clave como la supervisión humana o la discriminación.
Inigo DE MIGUEL BERIAIN
added a research item
In their recent article, Brown et al analyse several ethical aspects around immunity passports and put forward some recommendations for implementing them. Although they offer a comprehensive perspective, they overlook two essential aspects. First, while the authors consider the possibility that immunological passports may appear to discriminate against those who do not possess them, the opposite viewpoint of immune people is underdeveloped. We argue that if a person has been tested positive for and recovered from COVID-19, becoming immune to it, she cannot be considered a hazard to public health and, therefore, the curtailment of her fundamental rights is not legitimate. Second, they omit that vaccine distribution will create similar problems related to immunity-based licenses. Vaccine certificates will de facto generate a sort of immunity passport. In the next phases of the pandemic, different immunity statuses will be at stake, because the need to identify who can spread COVID-19 is unavoidable. If a person does not pose a threat to public health because she cannot spread the infection, then her right to freedom of movement should be respected, regardless of how she acquired that immunity.
Inigo DE MIGUEL BERIAIN
added a research item
Recently, the US Food and Drug Administration has given a landmark approval to the very first digital pill with a sensor embedded in the inside. These are complex systems that include a drug and an electronic tracker that is activated when the patient takes the pill. Accordingly, they might be an excellent tool for monitoring and potentially improving patients’ adherence to prescriptions. This would serve well to avoid unnecessary healthcare costs and reduce the anxiety of patients and their relatives. However, digital pills might also diminish patient autonomy, reduce privacy, or promote inadequate use of pharmaceutical resources. This article is aimed at contributing to adequate use of this new tool by showing the main ethical and social issues they involve and proposing measures meant to address them. Finally, we conclude by defending the idea that these new systems should be seen as means of complementing traditional strategies to promote adherence to treatment, and not as substitutes.
Guillermo Lazcoz
added 2 research items
Diagnosis and clinical decision-making based on Machine Learning technologies are showing significant advances that may change the functioning of our health care systems. They promise more effective and efficient healthcare at a lower cost. Even though evidence suggests that all these promises have yet to be demonstrated in clinical practice, it is undeniable that these technologies are already re-signifying the relationships on the health care landscape, particularly in the physician-patient relationship, which we can already redefine as a ‘physician-computer-patient relationship’. This new scenario is undoubtedly promising, but it also poses some fundamental issues that need an urgent answer. An inappropriate use of Machine Learning might involve a dramatic loss in the patients’ rights to informed consent or possible discrimination reflecting their personal circumstances. Unfortunately, the traditional principles incorporated by medical law are insufficient to face this challenge. Our most recent regulatory framework, defined by the General Regulation on Data Protection, might be useful in order to avoid this scenario since it includes the right not to be subject to a decision based solely on automated processing. In this paper, however, we argue that this legal tool is adequate but not sufficient to address the legal, ethical and social challenges that Machine Learning technologies pose to patients’ rights and health care givers’ capacities. Therefore, further development of the regulation on this topic and the development of new actors such as the Health Information Counsellors, will be necessary.
La Corte de Distrito de La Haya dictó el 5 de febrero de 2020 una sentencia sobre el Sistema de Indicación de Riesgos (SyRI), por la que considera que: i) es lícito utilizar instrumentos de este tipo siempre que exista un interés público que lo justifique y se tomen las medidas adecuadas para garantizar la mínima injerencia necesaria en el derecho a la privacidad; y ii) que la implementación de SyRI no ofrece garantías suficientes como para considerar que este sistema en concreto respeta el necesario juicio de proporcionalidad que debe superar toda injerencia en la privacidad de acuerdo con el artículo 8 del Convenio Europeo de Derechos Humanos (CEDH). A lo largo de este trabajo reflexionaremos en detalle sobre las consideraciones de la Corte en esta sentencia en relación con el respeto a la privacidad, la obtención masiva de datos y la opacidad con que funcionan los algoritmos de análisis de datos masivos.
Inigo DE MIGUEL BERIAIN
added a research item
Should we be allowed to refuse any involvement of artificial intelligence (AI) technology in diagnosis and treatment planning? This is the relevant question posed by Ploug and Holm in a recent article in Medicine, Health Care and Philosophy. In this article, I adhere to their conclusions, but not necessarily to the rationale that supports them. First, I argue that the idea that we should recognize this right on the basis of a rational interest defence is not plausible, unless we are willing to judge each patient’s ideology or religion. Instead, I consider that the right must be recognized by virtue of values such as social pluralism or individual autonomy. Second, I point out that the scope of such a right should be limited at least under three circumstances: (1) if it is against a physician’s obligation to not cause unnecessary harm to a patient or to not provide futile treatment, (2) in cases where the costs of implementing this right are too high, or (3) if recognizing the right would deprive other patients of their own rights to adequate health care.
Inigo DE MIGUEL BERIAIN
added a research item
This paper is part of the e-conference on « Data protection Issues and Covid-19: Comparative Perspectives » which consist in a daily publication at 12 p.m. (GMT+1) except on Sundays until the Summer break. A new session will start again at the beginning of the academic year 2020-21. This e-conference was organised by Dr. Yseult Marique, Senior Lecturer at the University of Essex and FÖV Speyer and Dr. Olivia Tambou, Associate Professor at the University of Paris-Dauphine, External Scientific Fellow at the Max Planck Institute of Luxembourg, and Founder- Editor of Blogdroiteuropeen.
Guillermo Lazcoz
added a research item
Esta ponencia fue impartida en la Jornada de debate "INTEL·LIGÈNCIA ARTIFICIAL EN SALUT" organizada por TIC Salut Social, Generalitat de Catalunya, celebrada en Barcelona el 11 de marzo de 2020.
Inigo DE MIGUEL BERIAIN
added a research item
Humbert G. Díaz
added an update
(EN): Online Course (No Fees): #Ethical and #Legal_Issues in #ICT & #Data_Protection, Massive Online Open Course (MOOC) Complementary for PhD/MSc and Deg students of #Computational_Sciences, #Data_Analysis,#Machine_Learning, #Cheminformatics, #Bioinformatics, #Law and#Legal_Sciences, #Medicine and #Biomedical_Research, .... , Organized by: Dra. Aliuska Duardo , Prof. Inigo DE MIGUEL BERIAIN , Prof. Carlos Romeo Casabona , ... Registration link: https://www.panelfit.eu/registration-ethical-and-legal-issues-regarding-ict-data-protection/ , Announced by #MOL2NET Conference and #USEDAT USA-EU Data Analysis Training Program, Reaching >70 People Registered!!! 👨‍🎓👩‍💼👩‍🔬👩‍⚖️👨‍🏫🙋‍♀️🙋‍♂️, Chair: Prof. Humbert G. Díaz, UPV/EHU, Ikerbasque, link: https://mol2net-06.sciforum.net/
(ES): Curson En Línea (Sin Costo) Buenas Noticias >70 Personas Registradas!!! 👨‍🎓👩‍💼👩‍🔬👩‍⚖️👨‍🏫🙋‍♀️🙋‍♂️. Curso abierto masivo en línea (MOOC) complementario para estudiantes de #doctorado, #maestría, o #grado en#Ciencias_computacionales, #Análisis_de_datos, #Bioinformática,#Inteligencia_Artifical, #Derecho, #Medicina etc., ... Enlace: https://www.panelfit.eu/registration-ethical-and-legal-issues-regarding-ict-data-protection/, Anunciado por Conferencia #MOL2NET y Program #USEDAT USA-EU de Entrenamiento en Análisis de Datos, Alcanzó Pico >70 Personas Registradas!!! 👨‍🎓👩‍💼👩‍🔬👩‍⚖️👨‍🏫🙋‍♀️🙋‍♂️, Chair: Prof. Humbert G. Díaz, UPV/EHU, Ikerbasque, link: https://mol2net-06.sciforum.net/
 
Guillermo Lazcoz
added a research item
Abstract: Discriminar es la razón de ser de los algoritmos de machine learning que se utilizan para elaborar perfiles personales. Discriminar para establecer diferentes precios, ofrecer determinada publicidad o dar acceso a un tratamiento médico. Lo cual no implica, necesariamente, que alguien haya sido discriminado en términos normativos. Este artículo describe el proceso que va desde la selección-discriminación que se realiza por medio de modelos algorítmicos, a la vulneración de la prohibición de discriminar. Y, por último, señala las debilidades de la actual normativa antidiscriminatoria para afrontar los retos planteados por estas tecnologías que gozan de pleno rigor matemático.
Aliuska Duardo
added an update
PANELFIT UPV/EHU Staff members have been guest editors of one of the special issues of the CTMC Series in Drug Dsicovery. This series of issues is published by the journal Curr Top Med Chem, ISSN: 1873-4294, IF = 3.44. EIC: Prof. Allen Reitz. They have published one open access editorial paper: New Experimental and Computational Tools for Drug Discovery: Medicinal Chemistry, Personalized Medicine, Ethical & Legal Issues - Part-V. Arrasate S, A. Duardo, Inigo DE MIGUEL BERIAIN, Carlos Romeo Casabona, Humbert G. Díaz . Curr Top Med Chem. 2018;18(25):2141-2142. doi: 10.2174/156802661825190118124556.http://www.eurekaselect.com/169128
 
Aliuska Duardo
added an update
We are glad to launch our Facebook page, come to visit us: https://www.facebook.com/Panelfit.news/
 
Aliuska Duardo
added an update
Computers, Privacy and Data Protection - CPDP, Brussels, #Health#data and #AI in #clinics and #research: #legal basis, transparency and accountability, Organised by: PANELFIT and Brussels Privacy Hub , https://brusselsprivacyhub.eu/events/cpdp2019panel.html Chair: Albena Kuyumdzhieva, European Commission, EU; Moderator: Gianclaudio Malgieri, Brussels Privacy Hub, BE; Speakers: Aliuska Duardo, University of the Basque Country UPV/EHU. Bernd Stahl, Director of the Centre for Computing and Social Responsibility, De Montfort Univ., UK; Zuzanna Warso, Helsinki Foundation for Human Rights, Europe of Human Rights, SIENNA Project, PL; Nicola Orlandi, Novartis, CH;
The panel will discuss the key challenges of health data processing in clinics and research under the GDPR and beyond: in particular, how to balance the protection of patients/data subjects with the interests of medical research. Relevant elements to consider are lawfulness, transparency and accountability. As regards lawfulness, it is necessary to explore the limits of informed and free consent (in particular in the case of data monetisation or where secondary data subjects are involved) and the opportunities to avoid consent requests (e.g. because of “public interests”). As regards transparency and accountability, a key challenge is the balancing between right to access (in particular when AI technologies are used) and public or private interests behind research. Some practical solutions will also be discussed, e.g. the helpfulness of DPIA or code of conducts in this field. How to deal with risks of using of new data-mining techniques in the context of clinics and how to protect rights and freedom of data subjects? It is well known that in the context of biomedical research there is a conflict between private and public interest. How should it be assessed in terms of data protection law? What are the main ethical, legal and governance issues related to AI in the health care context? How could we solve them? Registration: To register for the CPDP conference, please consult the CPDP Website.
 
Inigo DE MIGUEL BERIAIN
added an update
PANELFIT KO meeting was held in Frankfurt on 19/20 November 2018.
A joint event with the PRIVACY & US Network.
 
Aliuska Duardo
added an update
PANELFIT Kick-off Meeting, Goethe_Universität, Frankfurt, Germany, 2018, Nov, 19-20. Coord. Carlos Romeo Casabona , Inigo DE MIGUEL BERIAIN
 
Aliuska Duardo
added an update
PANELFIT: Participatory Approaches to a New Ethical and Legal Framework for ICT, two-fold brochure, authors: Aliuska Duardo, Inigo DE MIGUEL BERIAIN
 
Aliuska Duardo
added a project goal
Participatory Approaches to a New Ethical and Legal Framework for ICT (PANELFIT) Changes in the EU´S regulation of ICT research and innovation are opening a new scenario. Stakeholders, policy makers, and end users must adapt to them as soon as possible. This, however, might be hard. PANELFIT, a European Commission research´s project, is firmly committed to facilitating this adaptation process. Funding: >2790000 EUR. https://cordis.europa.eu/project/rcn/218355/en